Skip to main content
OpenTrials
Completed

NCT Number: NCT04196387

Antimicrobial Resistance Rate In Escherichia Coli And Klebsiella Pneumonia : A Retrospective Study

Antibiotics are medicines used to avoid and treat bacterial infections. Antibiotic resistance is increasing to dangerous level globally.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Age range

6 month–88 year

Sex eligibility

All sexes

Study type

Observational

About this study

Antibiotics resistance is a global health problem.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • patients with UTI
  • patients with dysuria
  • patients with loin pain

Exclusion criteria

  • patients with surgery
  • patients with cancer

Treatment and study plan

Urine Culture

Diagnostic Test

urine culture and antibiotic susceptibility test

Primary outcomes

  1. urine culture results

    Time frame: 3 years

    type of bacterial strain was isolated

Sponsors and collaborators

Lead sponsor

Batool Mutar

Other

Registry information

Important dates

Study start
2017
Primary completion
2019
Study completion
2019
First posted
Dec 12, 2019
Registry last updated
May 1, 2023

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.